» Articles » PMID: 24337727

Characterization of Cognitive Dysfunction in Sjögren's Syndrome Patients

Overview
Journal Clin Rheumatol
Publisher Springer
Specialty Rheumatology
Date 2013 Dec 17
PMID 24337727
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Sjögren's syndrome is an autoimmune disorder primarily affecting women, with decreased saliva and tear production as the principal characteristic. Cognitive, neurological, and psychiatric disorders also are associated with Sjögren's. The present study addressed the hypothesis that patients with Sjögren's syndrome differ significantly from matched controls in the prevalence and impact of a number of neuropsychiatric abnormalities. Sjögren's patients and controls (n = 37 per group) underwent medical and psychiatric evaluation, demographic assessments, quality of life and symptom evaluation, and extensive testing of cognitive function and memory. Patients and controls were closely matched for age, gender distribution, verbal IQ, marital status, educational level, employment status, and current/past medical or psychiatric history. On most subjective self-ratings, Sjögren's patients reported greater fatigue, impaired physical functioning, feeling depressed, and autonomic symptomatology compared to controls. Impaired memory was described mainly as loss of thought continuity in the midst of a task or activity. However, the majority of objective measures of cognition, psychomotor function, and memory showed minimal differences between groups. Sjögren's patients rate themselves as impaired on multiple ratings of emotional, cognitive, and physical function, but objective measures of cognition reveal fewer substantive differences between patients and matched controls. Sjögren's patients perceive deteriorated physical function over time, but they achieve a level of functioning comparable to controls despite the burden of their illness.

Citing Articles

Neurocognitive and Neuropsychiatric Implications of Fibrosing Interstitial Lung Diseases.

Vastag Z, Tudorache E, Traila D, Fira-Mladinescu O, Marc M, Oancea C Biomedicines. 2024; 12(11).

PMID: 39595138 PMC: 11591599. DOI: 10.3390/biomedicines12112572.


Hospitalization Risks for Neurological Disorders in Primary Sjögren's Syndrome Patients.

Goulabchand R, Gabelle A, Ayrignac X, Malafaye N, Labauge P, Noel D J Clin Med. 2022; 11(7).

PMID: 35407586 PMC: 9000167. DOI: 10.3390/jcm11071979.


Increased Risk of Sjögren's Syndrome in Patients with Obsessive-Compulsive Disorder: A Nationwide Population-Based Cohort Study.

Chang Y, Tseng J, Leong P, Wang Y, Cheng-Chung Wei J Int J Environ Res Public Health. 2021; 18(11).

PMID: 34205846 PMC: 8199316. DOI: 10.3390/ijerph18115936.


Cognitive impairment in patients with Neuro-Sjögren.

Seeliger T, Jacobsen L, Hendel M, Bonig L, Kristian Prenzler N, Thiele T Ann Clin Transl Neurol. 2020; 7(8):1352-1359.

PMID: 32628345 PMC: 7448149. DOI: 10.1002/acn3.51123.


Impact of pain on cognitive functions in primary Sjögren syndrome with small fiber neuropathy: 10 cases and a literature review.

Indart S, Hugon J, Guillausseau P, Gilbert A, Dumurgier J, Paquet C Medicine (Baltimore). 2017; 96(16):e6384.

PMID: 28422829 PMC: 5406045. DOI: 10.1097/MD.0000000000006384.


References
1.
Strombeck B, Ekdahl C, Manthorpe R, Wikstrom I, Jacobsson L . Health-related quality of life in primary Sjögren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36. Scand J Rheumatol. 2000; 29(1):20-8. DOI: 10.1080/030097400750001761. View

2.
Papas A, Fernandez M, Castano R, Gallagher S, Trivedi M, Shrotriya R . Oral pilocarpine for symptomatic relief of dry mouth and dry eyes in patients with Sjögrens syndrome. Adv Exp Med Biol. 1998; 438:973-8. DOI: 10.1007/978-1-4615-5359-5_139. View

3.
Bright P, Jaldow E, Kopelman M . The National Adult Reading Test as a measure of premorbid intelligence: a comparison with estimates derived from demographic variables. J Int Neuropsychol Soc. 2002; 8(6):847-54. DOI: 10.1017/s1355617702860131. View

4.
Alexander E . Central nervous system disease in Sjögren's syndrome. New insights into immunopathogenesis. Rheum Dis Clin North Am. 1992; 18(3):637-72. View

5.
Fox P, Bowman S, Segal B, Vivino F, Murukutla N, Choueiri K . Oral involvement in primary Sjögren syndrome. J Am Dent Assoc. 2008; 139(12):1592-601. DOI: 10.14219/jada.archive.2008.0101. View